Vuzix Corp - Quarter Report: 2013 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended June 30, 2013
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 000-53846
VUZIX CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 04-3392453 | |
State or other jurisdiction of incorporation or organization |
(I.R.S. Employer Identification No.) | |
2166 Brighton Henrietta Townline Rd Rochester, New York |
14623 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (585) 359-5900
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ¨ | Accelerated filer ¨ |
Non-accelerated filer ¨ (Do not check if a smaller reporting company) |
Smaller reporting company þ |
Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ¨ No þ
As of August 14, 2013, there were 9,541,153 shares of the registrant’s common stock outstanding.
Vuzix Corporation
INDEX
Page No. | |||
Part I – Financial Information | |||
Item 1. | Condensed Consolidated Financial Statements (Unaudited): | ||
Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012 | 3 | ||
Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2013 and 2012 | 4 | ||
Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2013 and 2012 | 5 | ||
Notes to the Unaudited Condensed Consolidated Financial Statements | 6 | ||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15 | |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 24 | |
Item 4. | Controls and Procedures | 24 | |
Part II – Other Information | |||
Item 1. | Legal Proceedings | 25 | |
Item 1A. | Risk Factors | 25 | |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 26 | |
Item 3. | Defaults Upon Senior Securities | 26 | |
Item 4. | Mine Safety Disclosure | 26 | |
Item 5. | Other Information | 26 | |
Item 6. | Exhibits | 26 | |
Signatures | 27 |
2 |
Part 1: FINANCIAL INFORMATION
Item 1: | Condensed Consolidated Financial Statements (Unaudited) |
VUZIX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
June 30, | December 31, | |||||||
2013 | 2012 | |||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash and Cash Equivalents | $ | 80,922 | $ | 66,554 | ||||
Accounts Receivable, Net | 225,540 | 170,600 | ||||||
Inventories (Note 5) | 486,101 | 687,181 | ||||||
Deferred Offering Costs (Note 6) | 340,479 | 199,571 | ||||||
Prepaid Expenses and Other Assets | 84,571 | 85,768 | ||||||
Total Current Assets | 1,217,613 | 1,209,674 | ||||||
Tooling and Equipment, Net | 512,848 | 664,967 | ||||||
Patents and Trademarks, Net | 551,461 | 551,307 | ||||||
Debenture Issuance Costs, Net | 214,602 | — | ||||||
Total Assets | $ | 2,496,524 | $ | 2,425,948 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current Liabilities | ||||||||
Accounts Payable | $ | 3,512,203 | $ | 2,896,567 | ||||
Lines of Credit (Note 7) | 112,500 | 112,500 | ||||||
Notes Payable (Note 8) | 492,673 | 258,209 | ||||||
Current Portion of Long-term Debt, net of discount | 1,682,310 | 1,060,188 | ||||||
Current Portion of Capital Leases | 34,830 | 57,244 | ||||||
Customer Deposits (Note 9) | 43,811 | 63,079 | ||||||
Accrued Interest | 407,387 | 161,703 | ||||||
Accrued Expenses (Note 10) | 718,811 | 519,672 | ||||||
Income Taxes Payable | 27,903 | 21,486 | ||||||
Derivative Liability (Note 11) | 915,560 | — | ||||||
Total Current Liabilities | 7,947,988 | 5,150,648 | ||||||
Long-Term Liabilities | ||||||||
Accrued Compensation (Note 12) | 1,110,096 | 1,010,096 | ||||||
Long Term Portion of Term Debt, net of discount (Note 13) | 1,319,138 | 1,715,253 | ||||||
Long Term Portion of Capital Leases | 26,381 | 40,041 | ||||||
Long Term Portion of Accrued Interest | 790,222 | 719,475 | ||||||
Total Long-Term Liabilities | 3,245,837 | 3,484,865 | ||||||
Total Liabilities | 11,193,825 | 8,635,513 | ||||||
Stockholders’ Equity (Deficit) | ||||||||
Series C Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 0 Shares Issued and Outstanding in Each Period | — | — | ||||||
Common Stock — $.001 Par Value, 700,000,000 Shares Authorized; 3,536,865 Shares Issued and Outstanding June 30, 2013 and December 31, 2012 | 3,537 | 3,537 | ||||||
Additional Paid-in Capital | 20,038,500 | 19,933,202 | ||||||
Accumulated (Deficit) | (28,739,338 | ) | (26,146,304 | ) | ||||
Total Stockholders’ Equity (Deficit) | (8,697,301 | ) | (6,209,565 | ) | ||||
Total Liabilities and Stockholders’ Deficit | $ | 2,496,524 | $ | 2,425,948 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
3 |
VUZIX
CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
For Three Months | For Six Months | |||||||||||||||
Ended June 30, | Ended June 30, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
Sales of Products | $ | 511,861 | $ | 590,686 | $ | 1,120,521 | $ | 1,504,627 | ||||||||
Sales of Engineering Services | 188,334 | 60,000 | 318,857 | 256,100 | ||||||||||||
Total Sales | 700,195 | 650,686 | 1,439,378 | 1,760,727 | ||||||||||||
Cost of Sales — Products | 315,280 | 446,080 | 597,291 | 1,120,106 | ||||||||||||
Cost of Sales — Engineering Services | 91,342 | 25,508 | 146,716 | 102,440 | ||||||||||||
Total Cost of Sales | 406,622 | 471,588 | 744,007 | 1,222,546 | ||||||||||||
Gross Profit | 293,573 | 179,098 | 695,371 | 538,181 | ||||||||||||
Operating Expenses: | ||||||||||||||||
Research and Development | 421,026 | 221,851 | 738,721 | 469,188 | ||||||||||||
Selling and Marketing | 287,741 | 285,796 | 562,484 | 622,976 | ||||||||||||
General and Administrative | 602,065 | 556,028 | 1,018,753 | 1,136,097 | ||||||||||||
Depreciation and Amortization | 90,612 | 122,452 | 188,960 | 267,548 | ||||||||||||
(Loss) from Operations | (1,107,871 | ) | (1,007,029 | ) | (1,813,547 | ) | (1,957,628 | ) | ||||||||
Other Income (Expense) | ||||||||||||||||
Interest and Other (Expense) Income | — | 232 | — | 279 | ||||||||||||
Foreign Exchange Gain (Loss) | 3,324 | 3,200 | (9,745 | ) | (1,742 | ) | ||||||||||
Loss on Derivative Valuation | (280,261 | ) | — | (294,548 | ) | — | ||||||||||
Amortization of Senior Term Debt Discount (Note 10) | (37,292 | ) | (6,327 | ) | (47,019 | ) | (12,651 | ) | ||||||||
Interest Expenses | (231,395 | ) | (151,485 | ) | (411,238 | ) | (240,257 | ) | ||||||||
Total Other Income (Expense) | (545,624 | ) | (154,380 | ) | (762,550 | ) | (254,371 | ) | ||||||||
(Loss) from Continuing Operations Before Provision for Income Taxes | (1,653,495 | ) | (1,161,409 | ) | (2,576,097 | ) | (2,211,999 | ) | ||||||||
Provision (Benefit) for Income Taxes | 3,241 | 5,967 | 16,937 | 22,969 | ||||||||||||
(Loss) from Continuing Operations | (1,656,736 | ) | $ | (1,167,376 | ) | (2,593,034 | ) | (2,234,968 | ) | |||||||
Income from Discontinued Operations (Note 16) | — | $ | (970,689 | ) | — | (747,580 | ) | |||||||||
Gain on Disposal of Discontinued Operations (Note 3) | — | $ | 5,902,663 | — | 5,902,663 | |||||||||||
Net Income (Loss) | (1,656,736 | ) | 3,764,598 | (2,593,034 | ) | 2,920,115 | ||||||||||
Earnings (Loss) per Share from Continuing Operations | ||||||||||||||||
Basic and Diluted | $ | (0.47 | ) | $ | (0.33 | ) | $ | (0.73 | ) | $ | (0.63 | ) | ||||
Earnings (Loss) per Share | ||||||||||||||||
Basic | $ | (0.47 | ) | $ | 1.06 | $ | (0.73 | ) | $ | 0.83 | ||||||
Diluted | $ | (0.47 | ) | $ | 1.02 | $ | (0.73 | ) | $ | 0.79 | ||||||
Weighted-average Shares Outstanding | ||||||||||||||||
Basic | 3,536,856 | 3,536,856 | 3,536,856 | 3,536,856 | ||||||||||||
Diluted | — | 3,677,064 | — | 3,677,064 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
4 |
VUZIX
CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
For the Six Months Ended | ||||||||
June 30, | ||||||||
2013 | 2012 | |||||||
Cash Flows from Operating Activities | ||||||||
Net Income (Loss) | $ | (2,593,034 | ) | $ | 2,920,115 | |||
Non-Cash Adjustments | ||||||||
Depreciation and Amortization | 188,960 | 258,279 | ||||||
Impairment of Patents and Trademarks | — | 9,268 | ||||||
Stock-Based Compensation Expense | 38,694 | 106,675 | ||||||
Amortization of Term Debt Discount | 47,019 | 764,899 | ||||||
Amortization of Debt Issuance Costs | 12,573 | — | ||||||
Loss on Derivative LiabilityValuation | 294,548 | — | ||||||
Gain on Sale of Discontinued Operation | — | (5,902,663 | ) | |||||
Non Cash Compensation | — | 74,072 | ||||||
(Increase) Decrease in Operating Assets | ||||||||
Accounts Receivable | (54,940 | ) | 629,055 | |||||
Inventories | 201,080 | 685,131 | ||||||
Prepaid Expenses and Other Assets | 1,197 | (69,085 | ) | |||||
Increase (Decrease) in Operating Liabilities | ||||||||
Accounts Payable | 615,635 | (1,060,609 | ) | |||||
Accrued Expenses | 105,899 | 29,261 | ||||||
Customer Deposits | (19,268 | ) | (357,737 | ) | ||||
Income Taxes Payable | 6,417 | (300 | ) | |||||
Accrued Compensation | 100,000 | 100,000 | ||||||
Accrued Interest | 316,431 | 495,272 | ||||||
Net Cash Flows (Used in) Provided by From Operating Activities | (738,789 | ) | (1,318,367 | ) | ||||
Cash Flows from Investing Activities | ||||||||
Proceeds from Sales of Assets, Net of Direct Costs | 7,574,304 | |||||||
Purchases of Tooling and Equipment | (10,051 | ) | (114,171 | ) | ||||
Investments in Patents and Trademarks | (26,944 | ) | (20,866 | ) | ||||
Net Cash (Used in ) Provided by From in Investing Activities | (36,995 | ) | 7,439,267 | |||||
Cash Flows from Financing Activities | ||||||||
Net Change in Lines of Credit | — | (652,091 | ) | |||||
Repayment of Capital Leases | (36,074 | ) | (52,090 | ) | ||||
Repayment of Long-Term Debt and Notes Payable | (148,421 | ) | (4,456,724 | ) | ||||
Proceeds from Senior Convertible Debt | 800,000 | — | ||||||
Issuance Costs on Senior Convertible Debt | (160,571 | ) | — | |||||
Proceeds from Notes Payable | 382,884 | 150,000 | ||||||
Costs paid for Proposed Private Placement | (47,666 | ) | — | |||||
Net Cash Flows (Used in) Provided by Financing Activities | 790,152 | (5,010,905 | ) | |||||
Net Increase (Decrease) in Cash and Cash Equivalents | 14,368 | 1,109,995 | ||||||
Cash and Cash Equivalents — Beginning of Period | 66,554 | 417,976 | ||||||
Cash and Cash Equivalents — End of Period | $ | 80,922 | $ | 1,527,971 | ||||
Supplemental Disclosures | ||||||||
Interest Paid | 85,036 | 338,785 | ||||||
Income Taxes Paid | 10,520 | 23,257 | ||||||
Discount on senior convertible debenture attributed to warrants | 621,012 | — | ||||||
Warrants granted for senior convertible debenture issuance costs | 66,603 | — |
The accompanying notes are an integral part of these condensed consolidated financial statements.
5 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 — Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information (“GAAP”) and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2012 was derived from the audited Consolidated Financial Statements in Form 10-K.
The accompanying condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2012, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.
The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.
The results of the Company’s former Tactical Display Group business have been classified and presented as discontinued operations in the accompanying unaudited condensed Consolidated Statement of Operations (Note 3). Prior period results have been adjusted to conform to this presentation. No other adjustments have been made to the unaudited condensed Consolidated Financial Statements and following notes.
All per share amounts, outstanding shares, warrants, options and shares issuable pursuant to convertible securities for all periods reflect the 1-for-75 reverse split of the Company’s common stock, which was effective February 6, 2013.
Note 2 — Liquidity and Going Concern Issues
The Company’s independent registered public accounting firm’s report issued on our consolidated financial statements for the years ended December 31, 2012 and 2011 included an explanatory paragraph describing the existence of conditions that raise substantial doubt about the Company’s ability to continue as a going concern, including continued operating losses and the potential inability to pay currently due debts. The Company has incurred a net loss from continuing operations consistently over the last 2 years. The net loss for the second quarter of 2013 was $2,593,034. The Company incurred annual net losses from its continuing operations of $4,747,387 in 2012 and $5,332,866 in 2011, and has an accumulated deficit of $28,739,338 as of June 30, 2013. The Company’s ongoing losses have had a significant negative impact on the Company’s financial position and liquidity.
The Company’s cash requirements are primarily for funding operating losses, working capital, research, principal and interest payments on debt obligations, and capital expenditures. Historically, the Company has met these cash needs by borrowings under notes, sales of convertible debt, the sales of equity securities and the sale of assets. There can be no assurance that the Company will be able to borrow or sell securities in the future, which raises substantial doubt about the ability of the Company to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.
With the sale of assets relating to the Company’s Tactical Display Group business (the “TDG Assets”) on June 15, 2012 and subsequent debt repayments, the Company was for a period no longer in default under the various covenants then contained in its agreements with its Convertible, Senior Secured Term loan lender and with its bank which provided Lines of Credit under a secured revolving loan agreement. This asset sale, debt repayments and other debt deferrals improved the working capital position of the Company. However due to its continued operating losses and the transition of its business away from its former military related product sales, the Company experienced further increase in its working capital deficiency.
6 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
In connection with the Company’s need for additional capital, on March 21, 2013, the Company issued a secured convertible debenture in the amount of $800,000. The debenture bears interest at a rate of 16% per year, payable quarterly in cash or shares of common stock at our option. Commencing on February 1, 2014, the Company will be required to redeem a certain amount under the debenture on a periodic basis in an amount equal to $200,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $50,000 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018.
The Company has not been in compliance with its minimum cash covenant as contained in its agreements with its Convertible, Senior Secured Term loan lender. Additionally the Company has not making its required monthly principal and interest payments to this lender and was behind $464,343 and $52,815, respectively in such payments as of June 30, 2013.
Management of the Company has been pursuing a financing to raise the additional capital needed to continue planned operations. On August 5, 2013, the Company closed on a public offering of common stock and warrants for a total of $8,050,000 in gross proceeds before underwriting discounts and commissions and other offering expenses payable by the Company. Please refer to Note 20 – Subsequent Events, for more details on the transaction.
The public offering and related debt conversions and repayments have allowed to Company to cure all its prior debt defaults. All of the Company’s secured debts were either repaid or converted into common stock and warrants simultaneously with the consummation of the public offering. Since the closing of the public offering, the Company has the financial resources to better execute on its business plans but it still must grow its business significantly to become profitable and self-sustaining on a cash flow basis. In the event that the Company is unable to do so in a timely manner, the Company would need to pursue other financing alternatives in the near future, which could include a private financing, bridge financing or collaboration agreements. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into such collaborative arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company’s stockholders. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate its research and development programs, future commercialization efforts or otherwise curtail its business, which could adversely affect its business prospects.
Note 3 — Discontinued Operations
In an effort to improve working capital, cure debt defaults and pay down debts, on June 15, 2012, the Company entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) between the Company and TDG Acquisition Company, LLC, a Delaware limited liability company (“TDG”). Pursuant to the Asset Purchase Agreement, the Company sold and licensed those of its assets (including equipment, tooling, certain patents and trademarks) (the “TDG Assets”) that comprised its tactical defense group, which engaged in the business of selling and licensing products and providing services, directly and indirectly, to military, defense and security organizations. The sale of the TDG Assets included sale of the Company’s proprietary Tac-Eye displays and its night vision electronics and optics module products. The Company received a worldwide, royalty free, assignable grant-back license to all the patents and other intellectual property sold to TDG, for use in the manufacture and sale of products other than in the military, defense and security markets. The Company retained the right to sell goods and services to other end user consumers, and to TDG and TDG and the Company jointly received the right to sell goods and services into all markets other than the military, defense and security markets and the consumer market. Under the Asset Purchase Agreement, TDG is allowed to sell its goods and services in all markets other than the consumer market or to end users. The Company and TDG also entered into a Vuzix Authorized Reseller Agreement, pursuant to which TDG is authorized as the exclusive reseller of the Company’s current and future products to military, defense and security organizations, unless TDG elects to have the Company make such sales directly.
The purchase price paid to the Company by TDG consists of two components: $8,374,900 net of adjustments, which was paid at closing, and up to an additional $2.5 million, which TDG will be required to pay only if TDG achieves certain quarterly and annual revenue targets from sales of goods and services to military, defense and security organizations. Based on financial reports submitted by TDG, none of the revenue targets were achieved, so no further amounts will be received by the Company. The purchase price was determined by arm’s length negotiations between the parties. We recorded a gain before taxes and final adjustments of $5,902,663 from the asset sale.
7 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The following represents the major components of the reported gain on sale:
Net Sales Price | $ | 8,374,900 | ||
Less: | ||||
- Professional Fees on Sale of Assets | (800,596 | ) | ||
- Accounts Receivable Sold | (299,599 | ) | ||
- Inventories Sold | (1,135,042 | ) | ||
- Fixed Assets Sold | (120,832 | ) | ||
- Patents and Trademarks Sold | (113,117 | ) | ||
- Sales Taxes on Asset Sale | (3,051 | ) | ||
Net Gain of Sale of Asset | $ | 5,902,663 |
In accordance with ASC 205-20, the sale of the TDG Assets has been accounted for as a discontinued operation. Accordingly, the operating results of the TDG Assets for the three and six months ended June 30, 2013 and 2012 have been reclassified as discontinued operations in the unaudited Condensed Consolidated Statement of Operations. Below is a summary of these results:
For Three Months | For Six Months | |||||||||||||||
Ended June 30, | Ended June 30, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
Sales of Products | $ | — | $ | 381,417 | $ | — | $ | 1,768,754 | ||||||||
Sales of Engineering Services | — | 4,907 | — | 358,921 | ||||||||||||
Total Sales | — | 386,324 | — | 2,127,675 | ||||||||||||
Total Cost of Sales | — | 287,038 | 1,273,908 | |||||||||||||
Gross Profit | — | 99,286 | — | 853,767 | ||||||||||||
Operating Expenses: | ||||||||||||||||
Research and Development | — | 131,216 | — | 295,138 | ||||||||||||
Selling and Marketing | — | 102,372 | — | 200,378 | ||||||||||||
General and Administrative | — | — | — | — | ||||||||||||
Depreciation and Amortization | — | — | — | — | ||||||||||||
Interest Expense on Senior Debt* | — | 147,114 | — | 353,583 | ||||||||||||
Amortization Senior Debt Discount* | — | 689,273 | — | 752,248 | ||||||||||||
Income (Loss) from Discontinued Operations | — | (970,689 | ) | — | (747,580 | ) | ||||||||||
Gain (Loss) on Disposal of Discontinued Operations | — | 5,902,663 | — | 5,902,663 | ||||||||||||
Provision (Benefit) for Income Taxes | — | — | — | — | ||||||||||||
Net Income (Loss) from Discontinued Operations | — | 4,931,974 | — | 5,155,083 | ||||||||||||
Basic Income (Loss) per Share | $ | — | $ | 1.39 | $ | — | $ | 1.40 | ||||||||
Diluted Income (Loss) per Share | $ | — | $ | 1.34 | $ | — | $ | 1.46 | ||||||||
Weighted-average Shares Outstanding | ||||||||||||||||
Basic | — | 3,536,865 | — | 3,536,865 | ||||||||||||
Diluted | — | 3,677,064 | — | 3,677,064 |
* Amounts reported represent the interest expense and the amortization of the discount on the Senior Term debt that was required to be repaid from the proceeds of the TDG Asset sale.
8 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 4 – Earnings (Loss) Per Share
Basic earnings (loss) per share is computed by dividing net income or loss by the weighted average number of common shares outstanding for the period. Diluted Earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants and the conversion of debt. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive. Had the Company reported net income for the three or six months ended June 30, 2013, a total of 1,327,595 shares would have been excluded from these diluted calculations as they would be anti-dilutive.
Note 5 — Inventories, Net
Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following as at June 30, 2013 and December 31, 2012:
June 30, 2013 | December 31, 2012 | |||||||
Purchased Parts and Components | $ | 371,622 | $ | 422,516 | ||||
Work in Process | 18,990 | 42,597 | ||||||
Finished Goods | 95,489 | 222,068 | ||||||
Net | $ | 486,101 | $ | 687,181 |
Note 6 — Deferred Offering Costs
Deferred offering costs consist principally of legal, accounting and underwriters’ fees incurred through to June 30, 2013 that are related to the public offering of the Company’s common stock and warrants and will be charged to capital as of the completion of the offering. Please refer to Note 20 – Subsequent Events.
Professional and Agents’ fees Paid | Professional and Agents’ fees Accrued | Total | ||||||||||
December 31, 2012 | $ | 57,500 | $ | 142,071 | $ | 199,571 | ||||||
Additions during period | 22,590 | 20,479 | 43,069 | |||||||||
March 31, 2013 | 80,090 | 162,550 | 242,640 | |||||||||
Additions during period | 25,076 | 72,763 | 97,839 | |||||||||
Deferred Offering Costs as of June 30, 2013 | $ | 105,166 | $ | 235,313 | $ | 340,479 |
Note 7 – Bank Lines of Credit
The Company has available a $112,500 line of credit with interest payable at the bank’s prime rate plus 1%. The line is unsecured and personally guaranteed by an officer of the Company. The outstanding balance on the line of credit amounted to $112,500 as of June 30, 2013 and December 31, 2012.
Note 8 – Notes Payable
Notes payable represent promissory notes payable by the Company.
June 30, 2013 | December 31, 2012 | |||||||
Note payable to officers and shareholders of the Company. Principal along with accrued interest is due and payable on March 31, 2014. The notes bear interest at 18.5% and secured by all the assets of the Company. | $ | 383,256 | $ | 165,738 | ||||
Note payable secured by all the assets of Company and the guarantee of its President and CEO. The effective interest rate is 31%. The note is to be repaid in 12 blended monthly payments of $5,645. | 79,824 | 46,737 | ||||||
Note payable to an officer of the Company due on December 31, 2013. The note bears interest at 7.49% and monthly principal payments of $2,691 plus accrued interest are required. The note is secured by all the assets of the Company. | 29,593 | 45,734 | ||||||
$ | 492,673 | $ | 258,209 |
9 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 9 — Customer Deposits
Customer deposits represent advance payments made by customers when they place orders for products. These deposits range from 20 to 100% of the total order amount. These deposits are credited to the customer against product deliveries or at the completion of their order.
Note 10 — Accrued Expenses
Accrued expenses consisted of the following:
June 30, 2013 | December 31, 2012 | |||||||
Accrued Wages and Related Costs | $ | 118,542 | $ | 31,197 | ||||
Accrued Compensation | 324,303 | 181,322 | ||||||
Accrued Professional Services | 126,827 | 181,227 | ||||||
Accrued Warranty Obligations | 44,408 | 93,788 | ||||||
Accrued Product Costs | 97,900 | — | ||||||
Other Accrued Expenses | 6,831 | 32,138 | ||||||
Total | $ | 718,811 | $ | 519,672 |
The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. The changes in the Company’s accrued warranty obligations for the three and six months ended June 30, 2013 were as follows:
2013 | ||||
Accrued Warranty Obligations at December 31, 2012 | $ | 93,788 | ||
Reductions for Settling Warranties | (41,042 | ) | ||
Warranties Issued During Period | 12,507 | |||
Accrued Warranty Obligations at March 31, 2013 | $ | 65,253 | ||
Reductions for Settling Warranties | (38,374 | ) | ||
Warranties Issued During Period | 17,529 | |||
Accrued Warranty Obligations at June 30, 2013 | $ | 44,408 |
Note 11 – Derivative Liability and Fair Value Measurement
The Company recognized a derivative liability for the warrants to purchase 186,480 shares of its common stock issued in connection with the $800,000 convertible senior secured debenture issued on March 21, 2013. These warrants have a cashless exercise provision effective six months after the issuance date and an exercise price that is subject to adjustment in the event of subsequent equity sales (subject to certain exceptions) within the first six months. In accordance with ASC 815-10-25, we measured the derivative liability using a Black-Scholes pricing model at the March 21, 2013 issuance date and subsequently remeasured the liability on June 30, 2013. See Note 15: Warrants for additional information on the warrants issued. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. The amount recorded for the derivative liability relating to the warrants as of March 21, 2013 was $621,012 and it was revalued to $635,299 as of March 31, 2013, resulting in a $14,287 loss on the derivative’s valuation for the first quarter. The derivative liability was revalued to $915,560 based on the closing price of our common shares as of June 30, 2013, resulting in a $280,261 loss on the derivative’s valuation for the second quarter and a $294,548 loss for the six-months ended June 30, 2013.
10 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The Company concluded that the Put embedded in the convertible debenture in the event of the Company’s default under the Debenture had such minimal value that it did not record an additional and separate liability for this contingency.
The Company has adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
- | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
- | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
- | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2013:
Total | (Level 1) | (Level 2) | Level (3) | |||||||||||||
Assets | $ | — | $ | — | $ | — | $ | — | ||||||||
Total assets measured at fair value | — | — | — | — | ||||||||||||
Liabilities | ||||||||||||||||
Derivative Liability | 915,560 | — | — | 915,560 | ||||||||||||
Total liabilities measured at fair value | $ | 915,560 | $ | — | $ | — | $ | 915,560 |
The Black-Scholes-Merton pricing model was used to estimate the fair value of warrants issued during 2013. The following summary table shows the assumptions used to compute the fair value of warrants issued during 2013 and their estimated value:
June 30, 2013 | March 21, 2013 (Issuance Date) | |||||||
Assumptions for Black-Scholes: | ||||||||
Expected term in years | 4.75 | 5.0 | ||||||
Volatility | 117.57 | % | 110.3 | % | ||||
Risk-free interest rate | 1.39 | % | 0.79 | % | ||||
Expected annual dividends | None | None | ||||||
Value of warrants issued: | ||||||||
Fair value of warrants granted | $ | 915,560 | $ | 621,012 |
Note 12 — Accrued Compensation
Accrued compensation represents amounts owed to officers of the Company for services rendered that remain outstanding. The principal is not subject to a fixed repayment schedule, and interest on the outstanding balances is payable at 8% per annum, compounding monthly. The unpaid principal amounts are shown as Long-Term Liabilities on the Company’s consolidated balance sheet. The respective interest amounts are included in Accrued Interest, under the Long-Term Liabilities section.
Accrued Compensation | Accrued Interest | |||||||
Balance as at December 31, 2012 | $ | 1,010,096 | $ | 442,638 | ||||
Additions in first quarter of 2013 | 50,000 | 29,315 | ||||||
Subtractions in first quarter of 2013 | — | — | ||||||
Balance as at March 31, 2013 | $ | 1,060,096 | $ | 471,953 | ||||
Additions in second quarter of 2013 | 50,000 | 31,095 | ||||||
Subtractions in second quarter of 2013 | — | — | ||||||
Balance as at June 30, 2013 | $ | 1,110,096 | $ | 503,048 |
On March 27, 2013, the Company entered into a deferred compensation deferral and conversion option agreements with two of its officer, which agreements were subject to the closing of the Company’s planned public stock offering by June 30, 2013, which was later extended to August 31, 2013, and which agreement is effective upon such closing. Pursuant to the deferred compensation and conversion option agreements the officers each agreed that the accrued compensation and accrued interest above, will be convertible into shares of the Company’s common stock, at a conversion price equal to the offering price of the Company’s proposed public stock offering. In connection with the closing of the public offering on August 5, 2013, the then loan amounts plus accrued interest are being converted in common shares and warrants. Please refer to Note 20 – Subsequent Events for further information.
11 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 13 — Long-Term Debt
Long-term debt consisted of the following:
June 30, 2013 | December 31, 2012 | |||||||
Note payable to an officer of the Company. The principal is not subject to a fixed repayment schedule, bears interest at 8% per annum and is secured by all of the assets of the Company | $ | 209,208 | $ | 209,208 | ||||
Note payable to an officer of the Company. The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company. | 225,719 | 225,719 | ||||||
Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months. The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal. | 396,004 (84,352) | 396,004 (97,003) | ||||||
Convertible, Senior Secured Term Debt. The principal is to be repaid over 15 months, with equal payments of principal beginning on October 15, 2012. The Company has not made any of the required principal payments and is in default and as a result the entire loan amount has been classified as current. The loan bears interest at 13.5%, per annum, which is payable monthly on the 15th of each month. The loan is secured by a first security position in all the Intellectual Property assets of the Company and a security interest in all of the other assets of the Company that is subordinate only to the security interest that secures the Company’s working capital loan. | 619,122 | 619,122 | ||||||
Convertible, Senior Secured Term Debenture. The principal is to be repaid on a periodic basis in an amount equal to $200,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $50,000 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018. The debenture bears interest at 16.0%, per annum, which is payable quarterly on each February 1, May 1, August 1 and November 1, beginning on August 1, 2013. The loan is secured by a first security position in all the assets of the Company. | 800,000 | — | ||||||
Discount related to Warrants issued pursuant to the above Convertible, Senior Term Debenture that was recorded as a derivative liability, net of $33,828 in amortization. | (586,644 | ) | — | |||||
Long-term secured deferred trade payable for which the principal and interest is subject to a fixed blended repayment schedule of 24 and 36 months, commencing July 15, 2013. The deferred trade payable bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company. | 1,320,643 | 1,320,643 | ||||||
Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company. | 101,748 | 101,748 | ||||||
$ | 3,001,448 | $ | 2,775,441 | |||||
Less: Amount Due Within One Year | (1,682,310 | ) | (1,060,188 | ) | ||||
Amount Due After One Year | $ | 1,319,138 | $ | 1,715,253 |
The aggregate maturities for all long-term borrowings as of June 30, 2013 are as follows:
2013 | 2014 | 2015 | 2016 | Thereafter | Total | |||||||||||||||||
$ | 1,682,310 | $ | 771,741 | $ | 338,189 | $ | — | $ | 209,208 | $ | 3,001,448 |
In connection with the sale of the TDG Assets, certain of the Company’s lenders entered into Loan Modification and Consent agreements pursuant to which each consented to the sale, as required by the loan agreements between the Company and each such lender, and released their security interests in the TDG Assets sold. Pursuant to a Loan Modification and Consent Agreement regarding the Company’s Convertible, Senior Secured Term Debt Loan, which was in default at the time of the sale, the Company paid this Senior Lender $4,450,000 in reduction of the obligations of the Company to the Senior Lender. The obligation of the Company to repay the remaining amount due to the Convertible Senior Secured Term Debt Lender, $619,122 was represented by a new note in that amount. This new note carries an interest rate of 13.5%, to be paid monthly. The principal amount of the note is to be repaid over 15 months, with equal principal payments commencing on October 15, 2012. The Company also agreed to use 40% of any of the earn-out payments received under the TDG Asset Purchase Agreement to reduce the principal of this new note. The Convertible Senior Secured Term Debt agreement contains certain covenants, including the maintenance of minimum cash, cash equivalents, and undrawn availability under any bank working capital line in an aggregate amount of at least 40% of the sum of (i) the outstanding principal amount of the loan and (ii) unpaid interest. The Company has not made any of its required principal payments and since February 2013 stopped making monthly interest payments. As a result the Company is default under its loan agreement with the lender.
12 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Pursuant to its original transaction with the holder of the Senior Secured Term Debt, the Company issued to that lender warrants to purchase up to 533,333 shares of common stock (the “Warrants”), at an exercise price of $7.47 per share, exercisable at any time prior to December 23, 2014. The fair value of these Warrants, $1,010,379 was reflected as a discount against the loan amount, but because of the loan’s restructuring and the early repayment of the principal resulting from the TDG Assets sale, the unamortized discount of $636,678 was fully expensed in the second quarter of 2012. The maximum number of shares of common stock that may be issued pursuant to: (i) the exercise of Warrants; and (ii) the conversion of principal and interest owing under the Loan, may not exceed 620,396 shares.
Pursuant to the various other Loan Modification and Consent agreements, each secured term note payable holders agreed to defer further payments on their respective Note Payable due from the Company until July 15, 2013 after which the notes are to be repaid in 24 to 36 equal monthly installments. Additionally the Company has agreed to use 15% of any of the earn-out payments received under the TDG Asset Purchase Agreement to reduce such Notes Payable.
On March 27, 2013, and amended thereafter, the Company entered into several debt conversion agreements with the respective holders of $2,374,682 of the long-term debt reflected in table above. Pursuant to the agreements, each lender agreed to convert its outstanding secured promissory note, together with accrued interest thereon into shares of the Company’s common stock, subject to the closing of the Company’s proposed public stock offering, at a conversion price equal to the public offering price. In connection with the closing of the public offering on August 5, 2013, $1,755,570 of these loan amounts plus accrued interest were converted in common shares and warrants and the remainder was repaid. Please refer to Note 20 – Subsequent Events for further information.
On March 21, 2013, the Company entered into a Securities Purchase Agreement with Hillair Capital Management L.P. (Hillair), pursuant to which, on March 21, 2013, the Company issued to Hillair a $800,000 16% secured convertible debenture due March 21, 2018. The debenture bears interest at a rate of 16% per year, payable quarterly in cash or shares of common stock at the Company’s option. Commencing on February 1, 2014, the Company is required to redeem a certain amount under the debenture on a periodic basis in an amount equal to $200,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $50,000 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018; which the Company may make in cash or common stock at our option subject to certain conditions. The debenture is convertible into shares of our common stock at a conversion price of $4.29 per share, subject to certain conversion price adjustments. In connection with the debenture issuance, the Company also issued to Hillair five-year warrants to purchase 186,480 shares of its common stock at an initial exercise price of $4.72 per share, which is subject to exercise price adjustments for the first six months. The warrants have been reflected as a derivative liability on the balance sheet and recorded as a discount against the debenture. See Note 11 for further details. Additional information regarding the debenture may be found in the Form 8-K filed by the Company on March 27, 2013. Upon the closing of the public offering, the warrant exercise was reduced to $2.25.
Upon closing of the debenture transaction, the Company retained Gentry Capital Advisors LLC (Gentry) as a financial advisor and agreed to pay Gentry a fee of $50,000 over a period of 4 months commencing upon the closing. The Company also issued to Gentry five-year warrants to purchase 20,000 shares of common stock at an exercise price of $4.72 per share, which warrant contained terms substantially similar to the warrants issued to Hillair. The fair value of these warrants was calculated as $66,603 and is reflected in the deferred debenture issuance costs below.
In connections with the issuance of the debenture the Company incurred issuance costs which totaled $227,174, inclusive of the financial advisor’s warrant discussed above. These costs will be amortized on a straight-line basis over the five year life of the debenture. Accumulated amortization to June 30, 2013 was $12,572.
Note 14 — Income Taxes
The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.
At December 31, 2012, the Company had unrecognized tax benefits totaling $5,151,000, which would have a favorable impact on the Company’s provision (benefit), if recognized.
13 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
In the three and six months ended June 30, 2013 and 2012, the Company generated federal and state net operating income for income tax purposes before the assumed offset against the Company’s net operating loss carry forwards. These federal and state net operating loss carry forwards total approximately $22,782,000 at June 30, 2013 and begin to expire in 2018, if not utilized. Of the Company’s tax credit carry forwards, $1,399,000 begin to expire in 2017, if not utilized.
Note 15 — Stock Warrants
A summary of the various changes in warrants during the six-month period ended June 30, 2013 is as follows.
Number of Shares | ||||
Warrants Outstanding at December 31, 2012 | 656,641 | |||
Exercised During the Period | — | |||
Issued During the Period | 206,480 | |||
Expired During the Period | (1,220 | ) | ||
Warrants Outstanding, June 30, 2013 | 861,901 |
A total of 206,480 warrants were issued during the six month period ending June 30, 2013 with an aggregate fair value $687,615, see Note 11 for further details. The outstanding warrants as of June 30, 2013 expire from December 31, 2013 to March 21, 2018. The weighted average remaining term of the warrants is 2.2 years. The weighted average exercise price is $6.84 per share. A total of 186,420 warrants was re-priced to $2.25 from $4.72 upon the closing of the public offering on August 5, 2013.
Note 16 — Stock Option Plans
A summary of stock option activity for the six-months ended June 30, 2013 is as follows:
Weighted | ||||||||||||
Average | ||||||||||||
Number of Shares | Exercise Price | Exercise Price Range | ||||||||||
Outstanding at December 31, 2012 | 192,729 | $ | 10.68 | $ | 1.70 – $ 17.50 | |||||||
Granted | — | $ | — | $ | — | |||||||
Exercised | — | $ | — | $ | — | |||||||
Expired or Forfeited | (518 | ) | $ | 11.25 | $ | 11.25 | ||||||
Outstanding at June 30, 2013 | 192,211 | $ | 10.67 | $ | 1.70 – $ 17.50 |
As of June 30, 2013, there were 165,159 options that were fully vested and exercisable at a weighted average exercise price of $10.52 per share. The weighted average remaining contractual term on the vested options is 5.2 years.
As of June 30, 2013 there were 27,052 unvested options exercisable at a weighted average exercise price of $10.50 per share. The weighted average remaining contractual term on the unvested options is 7.3 years.
No cash was received from option exercises for the three or six months ended June 30, 2013 and 2012.
The table below summarizes the impact of outstanding stock options on the results of operations for the three and three months ended June 30, 2013 and 2012:
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, 2013 | June 30, 2012 | June 30, 2013 | June 30, 2012 | |||||||||||||
Stock-based compensation expense: - - Stock Options | $ | 19,347 | $ | 49,272 | $ | 38,694 | $ | 106,669 | ||||||||
Income tax benefit | — | — | — | — | ||||||||||||
Net Decrease in Net Income | $ | 19,347 | $ | 49,272 | $ | 38,694 | $ | 106,699 | ||||||||
Per share increase in Loss Per Share: | ||||||||||||||||
Basic and Diluted | $ | 0.0055 | $ | 0.0139 | $ | 0.0109 | $ | 0.0302 |
14 |
VUZIX CORPORATION AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At June 30, 2013, the Company had approximately $127,911 of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately 1.2 years.
Note 17 — Litigation
We are not currently involved in any pending legal proceeding or litigation.
Note 18 — Contractual Obligations
The Company leases office and manufacturing space under operating leases that expire on September 30, 2013. The Company’s total contractual payment obligations for operating leases as of June 30, 2013 total $15,222 and are due in calendar year 2013.
Note 19 — Recent Accounting Pronouncements
There are no recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.
Note 20 — Subsequent Events
On August 5, 2013, the Company consummated its public offering of 4,250,000 shares of common stock, and warrants to purchase up to an aggregate of 4,250,000 shares of common stock, at a public offering price of $2.00 per share and $0.0001 per warrant. The warrants have a per share exercise price of $2.25, are exercisable immediately, and expire 5 years from the date of issuance. Total gross proceeds from the public offering were $8,050,000, before underwriting discounts and commissions and other offering expenses payable by Vuzix.
Simultaneous with the closing of this public offering $2,227,658 in outstanding secured debt and accrued interest thereon, converted into common stock and warrants at a conversion price equal to the offering price of $2.00. Additionally $1,532,051 in outstanding long-term accrued compensation and accrued interest owed to our officers was converted into common stock and warrants at a conversion price equal to the offering price of $2.00.
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
You should read the following discussion and analysis of financial condition and results of operations in conjunction with the financial statements and related notes appearing elsewhere in this interim report. As used in this report, unless otherwise indicated, the terms “Company,” “Vuzix” “management,” “we,” “our,” and “us” refer to Vuzix Corporation and its subsidiary.
Critical Accounting Policies and Significant Developments and Estimates
The discussion and analysis of our financial condition and results of operations are based on our unaudited consolidated financial statements and related notes appearing elsewhere in this quarterly report. The preparation of these statements in conformity with generally accepted accounting principles requires the appropriate application of certain accounting policies, many of which require us to make estimates and assumptions about future events and their impact on amounts reported in our financial statements, including the statement of operations, balance sheet, cash flow and related notes. We continually evaluate our estimates used in the preparation of our financial statements, including those related to revenue recognition, bad debts, inventories, warranty reserves, product warranty, carrying value of long-lived assets, valuation of stock compensation awards, and income taxes. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not apparent from other sources. Since future events and their impact cannot be determined with certainty, the actual results will inevitably differ from our estimates. Such differences could be material to the financial statements.
15 |
We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. These accounting policies and estimates are periodically reevaluated, and adjustments are made when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.
In reading our financial statements, you should be aware of the factors and trends that our management believes are important in understanding our financial performance. Since the sale of the TDG Assets in June 2012, we no longer sell night vision display drive electronics, the Tac-Eye line of Video Eyewear products, and a full range engineering services to defense customers, which will materially reduce our revenue and cash flow in the future. In accordance with ASC 205-20, the sale of the TDG Assets has been accounted for as discontinued operations and accordingly the operating results of the TDG Assets for the three months ended June 30, 2013 and 2012 have been reclassified as discontinued operations on our consolidated Statements of Operations. The critical accounting policies, judgments and estimates that we believe have the most significant effect on our financial statements are:
• | valuation of inventories; |
• | carrying value of long-lived assets; |
• | valuation of patents and trademarks; |
• | revenue recognition; |
• | product warranty; |
• | fair value measurement of financial instruments; |
• | embedded derivatives; | |
• | stock-based compensation; and |
• | income taxes. |
Our accounting policies are more fully described in the notes to our consolidated financial statements included in this quarterly report and in our annual report on Form 10-K for the year ended December 31, 2012. There have been no significant changes in our accounting policies for the three month period ended June 30, 2013.
Off Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on our financial condition, financial statements, revenues or expenses.
Business Matters
We are engaged in the design, manufacture, marketing and sale of devices that are worn like eyeglasses and feature built-in video screens that enable the user to view video and digital content, such as movies, computer data, the Internet or video games. Our products (known commercially as Video Eyewear, but also commonly referred to as virtual displays, wearable displays, personal viewers, Smart Glasses, head mounted displays (or HMDs), or near-to-eye displays (or NEDs)) are used to view high-resolution video and digital information primarily from mobile electronic devices (such as cell phones, portable media players, gaming systems and laptop computers) and from desktop computers. Our products provide the user a viewing experience that simulates viewing a large screen television or a desktop computer monitor and can be viewed practically anywhere, anytime.
Our Video Eyewear products feature high performance miniature display modules, low power electronics and related optical systems. We produce both monocular and binocular Video Eyewear devices that we believe are excellent solutions for many mobile computer or video viewing requirements. With respect to our Video Eyewear products, we focus on the consumer markets for gaming and mobile video while our Virtual and Augmented Reality products are also sold in the consumer, industrial, commercial, academic and medical markets. As a consequence of the sale of the TDG Assets, we no longer offer products directly to military organizations and defense or security organizations. The consumer electronics and mobile phone accessory markets in which we compete have been subject to rapid technological change including the rapid adoption of tablets and most recently larger screen sizes and display resolutions along with declining prices on mobile phones, and as a result we must continue to improve our products’ performance and lower our costs. We believe our intellectual property portfolio gives us a leadership position in microdisplay electronics, waveguides, ergonomics, packaging, motion tracking and optical systems.
Recent Accounting Pronouncements
There are no recent accounting pronouncements that are expected to have a material impact on the Company’s condensed consolidated financial statements.
16 |
TDG Asset Sale and Discontinued Operations
On June 15, 2012, we entered into an Asset Purchase Agreement with TDG Acquisition Company, LLC pursuant to which we sold the TDG Assets. The TDG Assets included equipment, tooling, certain patents and trademarks and our proprietary Tac-Eye displays and night vision display electronics, which comprised our tactical defense group, which engaged in the business of selling and licensing products and providing services, directly and indirectly, to military organizations and defense and security organizations. We received a worldwide, royalty free, assignable grant-back license to all the patents and other intellectual property sold for use in the manufacture and sale of products to the consumer markets. We retained the right to sell goods and services to the consumer market, and to the purchaser and the purchaser and we jointly received the right to sell goods and services into all markets other than the military, defense and security markets and the consumer market.
The purchase price paid to us consists of 2 components: $8,500,000 less $154,207 in adjustments, or $8,345,793, which was paid at closing, and up to an additional $2.5 million, which will be paid to us only if the purchaser achieves certain quarterly and annual revenue targets within the first 12 months after closing the sale of the TDG Assets from sales of goods and services to military organizations and defense and security organizations. Based on financial reports submitted by TDG as June 30, 2013, none of the revenue targets were achieved, so no further amounts will be received by the Company. The purchase price was determined by arm’s length negotiations between the parties.
In addition, the Asset Purchase Agreement provides that each of the parties will be precluded from conducting business in certain markets, which, in our case, is the sale of goods and services to military, defense and security organizations (provided, we may seek and perform contracts with certain identified government agencies related to our waveguide optics technology) and, in the case of the purchaser, is the sale of goods and services in the consumer markets or to end users. We and the purchaser also entered into a Vuzix Authorized Reseller Agreement, pursuant to which the purchaser was granted authorization to be the exclusive reseller of our current and future products to military, defense and security organizations (and was authorized to use our trademarks for such purpose), unless the purchaser elects to have us make such sales directly. This reseller agreement will be the main avenue for the distribution of any new products we may develop for the military and defense markets.
In connection with the Asset Purchase Agreement, we entered into a new letter agreement with LC Capital Master Fund Ltd., the senior lender under our convertible loan and security agreement and we executed a new note for $619,122, which represented the remaining obligation under the original December 2010 loan. The new note carries interest at a rate of 13.5% (18.5% if in default) and repayment is due in 12 equal payments commencing on October 15, 2012. We also agreed to use 40% of any of the earn-out received under the Asset Purchase Agreement in reduction of this note. We are in default under the loan agreement with the senior lender for failure to make required principal payments totaling $464,343 and interest payments totaling $52,815 as of June 30, 2013. This loan default was cured by the repayment of the entire principal amount and related accrued interest upon closing of the Company’s August 5, 2013 public offering. Please refer to Note 20 – Subsequent Events for further information.
In connection with the Asset Purchase Agreement, certain of our creditors entered into loan modification and consent agreements pursuant to which each consented to the sale of the TDG Assets, as required by the terms of existing loan agreements between us and each lender, and released their respective security interests in the TDG Assets. We were required to repay our bank line of credit as a condition to obtaining the required consent of the senior lender for the sale transaction, and the bank line of credit was canceled upon such repayment. Further, pursuant to the various loan modification and consent agreements, we made certain payments totaling $200,000 in reduction of the obligations owed and each lender agreed to defer further payments on their note payables until July 15, 2013 after which the notes are to be repaid in 24 to 36 monthly installments. Additionally, we have agreed to use 15% of any of the earn-out payments received pursuant to the Asset Purchase Agreement to reduce such notes payable.
In accordance with ASC 205-20, the sale of the TDG Assets has been accounted for as a discontinued operation. Accordingly, the operating results of the TDG Assets for the three and six months ending June 30, 2013 and 2012 have been reclassified as discontinued operations on our consolidated Statements of Operations and in the following discussion of our results of operations and financial condition.
Results of Operations
Comparison of Three Months Ended June 30, 2013 and June 30, 2012
Sales. Our sales were $700,195 for the second quarter ending June 30, 2013 compared to $650,686 for the same period in 2012. This represents a 7.6% increase for the three month period ending June 30, 2013 as compared to 2012. Product sales were $511,861 or 73% of total sales for the second quarter of 2013 as compared to $590,686 or 91% of our total sales for same period in 2012, a decrease of $78,825 or 13%. The decrease was primarily attributable to our limited working capital, which limited our ability to purchase components to build product to match our sales demand, particularly on new product lines. Sales from our engineering programs for the second quarter of 2013, increased to $188,334 or 27% of total sales compared to $60,000 or 9% of total sales in the same quarter 2012. The major reason for the increase was completion and delivery of waveguide HMD development program versus the prior period when progress billings were only being recorded.
17 |
Cost of Sales and Gross Profit. Gross profit increased to $293,573 for the second quarter of 2013 from $179,098 for the same period in 2012, an increase of $114,475 or 64%. As a percentage of net sales, gross profit increased to 42% for the second quarter of 2013 compared to 28% for the same period in 2012. This increase was primarily the result of a change in our overall sales mix to higher margin Video Eyewear models as compared to the same period in 2012.
Research and Development. Our research and development expenses increased by $199,175 or 90% in the second quarter of 2013, to $421,026 compared to $221,851 in the same period of 2012. The increase in spending was a direct result of our efforts to ready our new M100 smart glasses for release in the fourth quarter of 2013.
Selling and Marketing. Selling and marketing expenses were $287,741 for the second quarter of 2013 compared to $285,796 for the same period in 2012, a decrease of $1,945 or 1%. The decreases were primarily attributable to lower personnel salary costs and reduced external public relations consulting fees.
General and Administrative. General and administrative expenses were $602,065 for the second quarter of 2013 as compared to $556,028 for the same period in 2012, an increase of $46,037 or 8%. The overall increase in general and administrative costs reflects higher spending on legal fees and road show travel costs which were not deferred.
Depreciation and Amortization. Our depreciation and amortization expense for the second quarter of 2013 was $90,612 as compared to $122,452 in the same period in 2012, a decrease of $31,840 or 26%. The decrease was a direct result of a lower depreciable asset base after the sale of the TDG assets in 2013 versus the year 2012 when then asset still remained in the same period of 2012 and assets becoming fully depreciated.
Other (Income) Expense. Total other expenses was $545,624 in the second quarter of 2013 compared to $154,380 in the same period in 2012, an increase of $391,244. The increase in these expenses was primarily attributable to higher interest costs of $79,910 incurred in the second quarter of 2013 as compared to 2012, including interest on new loans received in the first quarter of 2013. Additionally we recorded a loss of $280,261 on the derivative liability valuation mark-to-market revaluation for the second quarter and the amortization of the additional senior debt discounts of $37,292 for the period ending June 30, 2013, as compared to $6,327 in 2012.
Provision for Income Taxes. The provision for income taxes for the second quarter of 2013 was $3,241 as compared to $5,967 for the same period in 2012.
Income from Discontinued Operations. The loss from Discontinued Operations was $970,689 for the three months ending June 30, 2012 as compared to Nil for same current period in 2013. For the second quarter of 2012, the Company reported Gain on Sale of $5,902,663, as compared to Nil for the same period in 2013. See Note 3 of the enclosed condensed consolidated financial statements for further information on the discontinued operations and gain on sale related to the TDG Assets.
Net Loss and Loss per Share. Our net loss was $1,656,736 or $0.47 basic loss per share in the second quarter ending June 30, 2013, compared to a net income of $3,764,598 or $1.06 per share for the same period in 2012.
Comparison of Six Months Ended June 30, 2013 and June 30, 2012
Sales. The Company’s sales were $1,439,378 for the six months ended June 30, 2013 compared to $1,760,727 for the same period in 2012. This represents a 18% decrease for the six month period 2013 as compared to 2012. Product sales decreased to $1,120,521 or 78% of total sales for the six months ended June 30, 2013 compared to $1,504,627 or 85% of the Company’s total sales as compared to the same period in 2012. The decrease of 26% in product sales was the direct result of our limited working capital and our inability to buy components to meet our sales demand which caused supply chain delays. Sales from the Company’s engineering programs, all related to waveguide based HMDs, for the six months ending June 30, 2013, increased to $318,857 or 22% of total sales compared to $256,100 or 14% of total sales in same period in 2012. The major reason for the increase was completion of program in the second quarter of 2013.
Cost of Sales and Gross Profit. Gross profit increased to $695,371 for the six months ending June 30, 2013 from $538,181 for the same period in 2012, an increase of $157,190 or 29%. As a percentage of net sales, gross profit increased to 48% for the six month period ending June 30, 2013 compared to 30% for the same period in 2012. This increase was the primarily the result of a change in our overall sales mix to higher margin consumer Video Eyewear and augmented reality models in 2013, versus the sales mix for the same period in the prior year when a larger percentage of our sales were from lower resolution Video Eyewear products which carried a lower average gross margin.
Research and Development. Our research and development expenses were $738,721 for the six months ending June 30, 2013 compared to $469,188 for the same period in 2012. The $269,533 or 57% increase in the 2013 period versus 2012 was a direct result of our efforts to ready our new M100 smart glasses for release in the fourth quarter of 2013.
18 |
Selling and Marketing. Selling and marketing expenses were $562,484 for the six months ending June 30, 2013 compared to $622,976 for the same period in 2012, a decrease of $60,492 or 10%. The decreases were mainly attributable to lower personnel salary costs.
General and Administrative. General and administrative expenses were $1,018,753 for the six months ending June 30, 2013 as compared to $1,136,097 for the same period in 2012, a decrease of $117,344 or 10%. The lower general and administrative costs related to lower salary costs and reduced rent and occupancy expenses.
Depreciation and Amortization. Our depreciation and amortization expense for the six months ending June 30, 2013 was $188,960 as compared to $267,548 in the same period in 2012, a decrease of $78,588 or 29%. The decrease was a direct result of a lower depreciable asset base after the sale of the TDG assets in 2013 versus the year 2012 when then asset still remained in the same period of 2012 and assets becoming fully depreciated.
Other Income (Expense). Total other expenses were $(762,550) for the six period ending June 30, 2013 compared to $(254,371) in the same period in 2012, an increase of $(508,179). The increase in these expenses was primarily attributable to interest costs, loss on derivative valuation and the amortization of senior term debt discounts. Interest expense increased by $(170,981) or 71% due to new loans and the higher default interest rate costs on certain senior debt which was in default in the 2013 period. The Company recorded a loss of $(294,548) on the derivative liability valuation mark-to-market revaluation for the 2013 period versus nil in 2012. The amortization of the senior term debt discount was $(47,019) as compared to $(12,651) for same period in 2012.
Provision for Income Taxes. The provision for income taxes for the six months ending June 30, 2013 was $16,937 as compared to $22,969 for the same period in 2012.
Income from Discontinued Operations and Gain on Sale of Discontinued Assets. The loss from Discontinued Operations was $747,580 for the six months ending June 30, 2012 as compared to Nil for same current period in 2013. In the 2012 comparative period, the Company reported Gain on Sale of $5,902,663, as compared to Nil for the same period in 2013. See Note 3 of the enclosed condensed consolidated financial statements for further information on the discontinued operations and gain on sale related to the TDG Assets.
Net Income (Loss) and Income (Loss) per Share. Our net income was $(2,593,034) or $(0.73) basic per share for the six months ending June 30, 2012, versus income of $2,920,115 or $0.83 for the same period in 2012.
Liquidity and Capital Resources
As of June 30, 2013, we had cash and cash equivalents of $80,922 an increase of $14,368 from $66,554 as of December 31, 2012.
At June 30, 2013 we had current liabilities of $7,947,988 compared to current assets of $1,217,613 which resulted in a negative working capital position of $6,730,375. As at December 31, 2012 we had a negative working capital position of $3,940,974. Our current liabilities are comprised principally of the current portion of long term debt, accounts payable, accrued expenses, customer deposits, notes payable, bank lines of credit and a derivative liability.
Our continuation as a going concern is dependent upon our attaining and maintaining profitable operations and raising additional capital and/or selling certain assets. Prior to June 15, 2012, we were in default under our loan agreements with our senior lenders under our senior term debt. The sale of the TDG Assets allowed us to repay a significant portion of our senior term debt, which was in default at the time of sale. Most of our other lenders entered into loan modification agreements pursuant to which they consented to the TDG Assets sale and agreed to defer any debt payments until after July 15, 2013. We repaid our previous bank line of credit on June 15, 2012, which was cancelled on that date, and will seek to obtain a new line of credit. There is no assurance that a replacement credit facility can be negotiated, or the amount and terms of any future bank drawings.
As of June 30, 2013 the Company was in default under its loan agreement with LC Capital Master Fund Ltd., a senior secured lender for failure to comply with a minimum cash covenant and failure to make scheduled principal payments in the total amount of $464,343 and $52,815 in accrued interest, as per the terms of that loan agreement. This senior secured lender was as of June 30, 2013 able to exercise its remedies under the loan agreement, including acceleration of the amounts due and foreclosure and sale of the collateral held by it. Upon the closing of our August 5, 2013 public offering, as described in Note 20 of the condensed financial statements and below, this loan default was cured by the repayment of the entire principal amount and related accrued interest upon closing.
19 |
Operating Activities. We used $738,789 of cash for operating activities for the six months ending June 30, 2013 and $1,272,451 in the same period in 2012. Changes in non-cash operating assets and liabilities were $1,224,785 for the six months ending June 30, 2013 and $450,988 in the same period in 2012. The major non-cash operating items for the six months ending June 30, 2013 resulted from a $615,635 increase in accounts payable, a $100,000 increase in accrued compensation, a $316,431 increase in accrued interest and a $199,141 increase in accrued expenses. The major non-cash operating items for first half of 2012 resulted from a $685,131 reduction in inventory and a $629,055 reduction in accounts receivable, a $(357,737) reduction in customer deposits, along with a $495,272 increase in accrued interest. Included in these reductions were $299,599 in accounts receivable and $938,549 in inventory related to the sale of the TDG Assets.
Investing Activities. Cash used in investing activities was $36,995 for the six months ending June 30, 2013. Cash used for investing activities of $10,051 in the first half of 2013 related primarily to the purchase of computer equipment additions. The costs of registering our intellectual property rights, included in the investing activities totals described above, were $26,944 in the six month period ending June 30, 2013.
Cash provided by investing activities was $7,439,267 in the first half of 2012. Cash used for investing activities of $(114,171) in the first half of 2012 related primarily to the purchase of computer equipment additions and tooling, and the costs of registering our intellectual property rights, included in the investing activities totals described above, were $(20,866). From the sale of the TDG Assets in June 2012 the Company received proceeds of $8,374,900 less expenses of $(800,593) or a net of $7,574,304.
Financing Activities. Cash provided by financing activities was $790,152 for the six months ending June 30, 2013. During the six month period ending June 30, 2013, the primary source of cash were the proceeds of $800,000 from the sale of a convertible debenture less issuance costs of $160,439 and $382,884 from the sale of notes payable, less the repayment of $(148,421) in notes payable.
Cash (used in) financing activities was $(5,010,905) in the first half of 2012. During the first half of 2012, the primary use of cash was a $(652,091) reduction in drawings under our operating line of credit and the repayments on term debt of $(4,456,724) as required by our lenders for their approval of the sale of the TDG Assets.
Capital Resources. As of June 30, 2013, we had a cash balance of $80,922. The outstanding balance under our line of credit as of June 30, 2013 was $112,500, the same amount as of December 31, 2012. We anticipate that to meet our working capital needs, we will need to negotiate a new operating credit facility with its bank or seek alternative sources for an operating loan.
The TDG Asset sale and subsequent debt restructurings improved our working capital position and reduced our working capital deficit; however, due to our continued operating losses and business transition away from our prior TDG Assets business activities, the Company experienced a further rise in its working capital deficiency.
On August 5, 2013, the Company consummated its public offering of 4,250,000 shares of common stock, and warrants to purchase up to an aggregate of 4,250,000 shares of common stock, at a public offering price of $2.00 per share and $0.0001 per warrant. The warrants have a per share exercise price of $2.25, are exercisable immediately, and expire 5 years from the date of issuance. Total gross proceeds from the public offering were $8,050,000, before underwriting discounts and commissions and other offering expenses payable by the Company.
Simultaneous with the closing of this public offering $2,316,006 in outstanding secured debt and accrued interest thereon, converted into common stock and warrants at a conversion price equal to the offering price of $2.00. Additionally $1,642,569 in outstanding long-term accrued compensation and accrued interest owed to our officers was converted into common stock and warrants at a conversion price equal to the offering price of $2.00.
The Company intends to use the net proceeds received from the offering to complete commercialization of the M100 Smart Glasses, winner of the Best of Innovations and Engineering award at the 2013 Consumer Electronics Show (CES), and the VFX720 video head phone products, and waveguide technologies, repayment of certain of debt (consisting of principal and interest on outstanding notes, convertible debentures and bank loans) in the amount of approximately $2,025,000 , and for working capital and general corporate purposes.
The following discussion and analysis should be read in conjunction with the consolidated financial statements and related notes appearing elsewhere and in our annual report on Form 10-K for the year ended December 31, 2012. During the three and six months ending June 30, 2013 and the years ended December 31, 2012 and 2011, we have has been unable to generate cash flows other than our recent asset sales, sufficient to support our operations and have been dependent on term debt financings, equity financings, revolving credit financing and most recently asset sales and our public offering. We will remain dependent on outside sources of funding until our results of operations provide positive cash flows. There can be no assurance that we will be able to generate cash from those sources in the future. Our independent auditors issued a going concern paragraph in their reports for the years ended December 31, 2012 and 2011. The accompanying financial statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern. As a result of our current level of funding, ongoing losses from operations, substantial doubt exists about its ability to continue as a going concern.
20 |
Our cash requirements depend on numerous factors, including new product development activities, our ability to commercialize our products, their timely market acceptance, selling prices and gross margins, and other factors. To the extent we have sufficient operating funds, we expect to carefully devote capital resources to continue our waveguide and HD display engine development programs, hire and train additional staff, and undertake new product marketing activities. Such expenditures, along with further future net operating losses, product tooling expenses, and related working capital investments, will be the principal use of our cash.
We have previously attracted funding in the form of subordinated debt, a bank line of credit and most recently a public offering of common shares and warrants. However, there can be no assurance that we will be able to do so in the future or that if we raise additional capital it will be sufficient to execute our business plan. To the extent that we are unable to raise sufficient additional capital, we will be required to substantially modify our business plan and our plans for operations, which could have a material adverse effect on us and our financial condition.
We also rely on credit lines from key suppliers and customer deposits in managing liquidity. As a result, if our trade creditors were to impose unfavorable terms or customers decline to make advance deposits for their orders, it would negatively impact our ability to obtain products and services on acceptable terms, produce products and operate our business.
On March 8, 2013 we entered into and closed a Promissory Note and Security Agreement with our senior lender pursuant to which it made a $100,000 secured loan to us. The loan was repaid on March 27, 2013 with the proceeds received from the sale of the debenture made on that date (discussed below).
On March 21, 2013 we entered into a Securities Purchase Agreement with Hillair Capital Management L.P. (Hillair), pursuant to which, on March 27, 2013, we issued to Hillair a $800,000 16% senior secured convertible debenture due on March 21, 2018. The debenture bears interest at a rate of 16% per year, payable quarterly in cash or shares of common stock at our option. Commencing on February 1, 2014, we will be required to redeem a certain amount under the debenture on a periodic basis in an amount equal to $200,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $50,000 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018,which we may make in cash or common stock at our option subject to certain conditions. The debenture is convertible into shares of our common stock at a conversion price of $4.29 per share. In connection with the debenture issuance, we also issued to Hillair five-year warrants to purchase 186,480 shares of our common stock at an exercise price of $4.72 per share. Upon the closing of our public offering on August 5, 2013, the exercise price of the warrants was reduced to $2.25. Upon closing of this transaction, we retained Gentry Capital Advisors LLC (Gentry) as a financial advisor and agreed to pay Gentry a fee of $50,000 over a period of 4 months commencing upon the closing. We also issued to Gentry five-year warrants to purchase 20,000 shares of our common stock at an exercise price of $4.72 per share. The entire principal amount and related accrued interest of this loan along with a $200,000 early repayment penalty was repaid upon the closing of the Company’s public offering on August 5, 2013.
We are using the proceeds from the sale of the debenture for general working capital purposes and to accelerate the tooling and development work on our Smart Glasses products.
On July 15, 2013, we entered into and closed a securities purchase agreement with Hillair whereby we sold to Hillair, for a purchase price of $200,000, (i) a $200,000 16% senior secured convertible debenture due March 21, 2018, and (ii) a common stock purchase warrant to purchase up to 38,168 shares of our common stock. The debenture is convertible into shares of common stock at a conversion price of $5.24 per share, subject to adjustments upon certain events. Interest on the Debenture accrues at the rate of 16% annually and is payable quarterly on February 1, May 1, August 1 and November 1, beginning on August 1, 2013, on any redemption, conversion and at maturity. Interest is payable in cash or at our option in shares of our common stock, provided certain conditions are met. Commencing on February 1, 2014, we will be obligated to redeem a certain amount under the debenture on a periodic basis in an amount equal to $50,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $12,500 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018. In lieu of a cash redemption and subject to our meeting certain equity conditions, we may elect to pay the such required redemption amounts in shares. The warrants may be exercised at any time on or after July 15, 2013 until March 21, 2018, and had an initial exercise price of $5.24 per share, subject to adjustments upon certain events, which was reduced to $2.25 upon the closing of our public offering on August 5, 2013. Our obligations under the debenture are secured under the terms of the security agreement dated as of March 27, 2013 between us, our subsidiaries and Hillair and the Subsidiary Guarantee dated March 27, 2013 between Hillair and our subsidiaries. The entire principal amount and related accrued interest of this loan along with a $40,000 early repayment penalty was repaid upon the closing of the Company’s public offering on August 5, 2013.
We intend to take actions necessary for us to continue as a going concern, as discussed herein, and accordingly our consolidated financial statements have been prepared assuming that we will continue as a going concern. The unaudited consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Management’s plans concerning these matters are discussed below and in Note 2 to the unaudited condensed consolidated financial statements. The August 5, 2013 successful closing of the Company’s public offering for gross proceeds of $8,050,000 and the conversion of approximately $3,960,000 in debt and accrued interest into common stock in connection therewith has significantly improved the financial position of the Company. We believe these financings have provided us sufficient capital to implement our current operating plan and planned new product development activities and reduced the doubt about our ability to continue as a going concern for at least 12 months. The Company must still grow its business significantly to become profitable and self-sustaining on a cash flow basis.
21 |
Additionally we plan to manage our liquidity under an operational plan that contemplates, among other things:
• | managing our working capital through better optimization of inventory levels; |
• | focusing on selling higher gross margin products, which will mean a greater emphasis on augmented reality products; |
• | the introduction of the M100, waveguide optics and new high resolution Smart Glasses; |
• | reducing and deferring some research and development and delaying some planned product and new technology introductions; |
• | exploring our options with respect to new equity financings or debt borrowings; and |
We cannot make assurances as to whether any of these actions can be effected on a timely basis, on satisfactory terms or maintained once initiated, and even if successful, whether our liquidity plan will limit certain of our operational and strategic initiatives designed to grow our business over the long term or whether such initiatives will be limited by the availability of capital. We cannot make assurances that we will be able to generate sufficient cash flow from operations, service our remaining indebtedness or otherwise fund our new product development plans.
If we are required to raise additional funds by selling additional shares of our capital stock, or securities convertible into shares of our capital stock, the ownership interest of our existing shareholders may be diluted. The amount of dilution could be increased by the issuance of warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets. We can give no assurance that we will be able to obtain additional financing on favorable terms or at all. If we are unable to become profitable and self-sustaining on a cash flow basis and are required to obtain future funding, the Company could be forced to delay, reduce or eliminate its research and development programs, future commercialization efforts or otherwise curtail its business, which could adversely affect its business prospects. These factors raise substantial doubt about our ability to continue as a going concern.
Forward Looking Statements
This quarterly report includes forward-looking statements. These statements are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include statements concerning:
· | Our cash needs and financing plans; | |
· | Our possible or assumed future results of operations; | |
· | Our business strategies; | |
· | Our ability to attract and retain customers; | |
· | Our ability to sell additional products and services to customers; | |
· | Our competitive position; | |
· | Our industry environment; | |
· | Our potential growth opportunities; | |
· | Expected technological advances by us or by third parties and our ability to leverage them; | |
· | The effects of future regulation; and | |
· | The effects of competition. |
All statements in this quarterly report that are not historical facts are forward-looking statements. We may, in some cases, use terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking statements.
22 |
The outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These important factors include our financial performance and the other important factors set forth in our annual report on Form 10-K for the year ended December 31, 2012 and in other filings with the Securities and Exchange Commission.
All such forward-looking statements are subject to certain risks and uncertainties and should be evaluated in light of important risk factors. These risk factors include, but are not limited to, those that are described in “Risk Factors” under Item 1A and elsewhere in our 2012 annual report on Form 10-K and the following: business and economic conditions, rapid technological changes accompanied by frequent new product introductions, competitive pressures, dependence on key customers, inability to gauge order flows from customers, fluctuations in quarterly and annual results, the reliance on a limited number of third party suppliers, limitations of our manufacturing capacity and arrangements, the protection of our proprietary technology, the effects of pending or threatened litigation, the dependence on key personnel, changes in critical accounting estimates, potential impairments related to investments, foreign regulations, liquidity issues, our material working capital deficiency, and potential material weaknesses in internal control over financial reporting. Further, during weak or uncertain economic periods, customers’ may delay the placement of their orders. These factors often result in a substantial portion of our revenue being derived from orders placed within a quarter and shipped in the final month of the same quarter. In addition, the recent sale of our TDG Assets has resulted in a change in focus for us because, since inception, a substantial portion of our sales have been derived from the sale of night vision display drive electronics, sales of our Tac-Eye monocular video eyewear and engineering services primarily to the U.S. government and its suppliers. As a result of our sale of the TDG Assets, we no longer sell night vision display drive electronics, sell our former Tac-Eye products or perform general engineering services to defense customers and this has materially reduced our revenue and cash flow and could materially adversely affect our ability to achieve or maintain profitability in the future. Any future defense related sales will be limited to engineering services regarding our waveguide optics and, eventually, the sale of products based on that technology and defense-related sales made through TDG. Our ability to fully replace the revenues from the sold TDG Asserts and product lines is unknown.
Any of these factors could cause our actual results to differ materially from our anticipated results. For a more detailed discussion of these factors, see the "Risk Factors" discussion in Item 1A in our 2012 annual report. We caution readers to carefully consider such factors. Many of these factors are beyond our control. In addition, any forward-looking statements represent our estimates only as of the date they are made, and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, except as may be required under applicable securities laws, we specifically disclaim any obligation to do so, even if its estimates change.
23 |
Item 3. | Quantitative and Qualitative Disclosures about Market Risk |
Not applicable
Item 4. | Controls and Procedures |
Disclosure Controls and Procedures
We maintain a system of disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (SEC) rules and forms. Disclosure controls are also designed to reasonably assure that such information is accumulated and communicated to management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate to allow timely decisions regarding required disclosure. Disclosure controls include components of internal control over financial reporting, which consists of control processes designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP.
As reported in our 2012 Annual Report on Form 10-K (the "2012 Form 10-K"), as of December 31, 2012, our management identified material weaknesses in our internal control over financial reporting that have a direct impact on our financial reporting. Due to these material weaknesses in internal control over financial reporting, our management concluded in our 2012 Form 10-K that our disclosure controls and procedures were ineffective as of December 31, 2012.
Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2013. As part of its evaluation, our management has evaluated whether the control deficiencies related to the reported material weakness in internal control over financial reporting continue to exist. As of June 30, 2013, we have not completed the development, assessment, implementation and testing of the changes in controls and procedures that we believe are necessary to conclude that the material weakness has been remediated and, therefore, our management has concluded that we cannot assert that the control deficiencies relating to the reported material weakness have been effectively remediated. As a result, our CEO and CFO have concluded that our disclosure controls and procedures were ineffective as of June 30, 2013.
In light of the foregoing conclusion, we undertook additional procedures in order that management could conclude that reasonable assurance exists regarding the reliability of financial reporting and the preparation of the consolidated financial statements contained in this filing. Accordingly, management believes that our consolidated financial statements included in this Quarterly Report on Form 10-Q for the period ended June 30, 2013 fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reports as of December 31, 2012, we determined that there were control deficiencies that constituted the following material weaknesses that continue to exist as of June 30, 2013:
Deficiencies in Financial Reporting and Close Process
Our current financial close process does not ensure accurate financial reporting on a timely basis. We also did not maintain effective controls over the period-end financial close and reporting processes in relation to the consolidation of our subsidiary’s financial information. The specific deficiencies contributing to this material weakness related (a) to inadequate policies and procedures, (b) ineffective procedures and controls over journal entries, accruals and reserves, (c) inadequate controls and procedures related to the timely preparation and review of account reconciliations, (d) inadequate segregation of duties, (e) inadequate controls over cut-off procedures, (f) deficiencies in end-user computing controls of critical spreadsheets, and (g) an insufficient complement of personnel with appropriate levels of knowledge and experience. Due to the actual and potential errors on financial statement balances and disclosures, management has concluded that these deficiencies in internal controls over the period-end financial close and reporting processes constituted a material weakness in internal control over financial reporting. We intend to establish and document financial close processes and procedures including responsibilities and due dates. We also intend to commence utilizing a closing checklist to ensure all procedures are performed and appropriate reviews are completed on a timely basis for each quarter and year-end period. Additionally, we intend to implement controls over critical spreadsheets, including change control, input control, access and data security and appropriate review procedures. Further, we intend to seek additional resources with strong accounting and reporting experience when financial resources are available. We cannot give any assurance as to whether or when we will be able to implement those changes.
24 |
Deficiencies in Segregation of Duties
There is limited segregation of duties which could result in a material misstatement in our financial statements. Given our staff levels, certain duties within the accounting and finance department cannot be properly segregated. However, we believe that none of these segregation of duty deficiencies resulted in material misstatement in the financial statements as we rely on certain compensating controls, including periodic substantive review of the financial statements by the Chief Executive Officer and Chief Financial Officer.
Deficiencies in Monitoring of Subsidiaries
We have not designed adequate monitoring controls related to our European subsidiary or Japanese branch sales office, such that we can be assured that a material misstatement of financial results would be prevented or detected on a timely basis.
Weaknesses in Inventory Controls
We have identified weaknesses in our inventory controls as follows:
· | Documented processes and controls are insufficient and are not working effectively for several key inventory processes including inventory adjustments and reserves for excess, defective and obsolete inventory. |
· | Inventory valuation processes and controls are not sufficiently documented and are not working effectively including costs to be expensed versus inventoried and maintenance of adequate supporting documentation for current unit costs and bill of materials. |
Deficiencies in Internal Controls Procedures and Risk Assessment Program
We have concluded that formal written internal control policies and procedures do not currently exist for all areas within our operations. A well-established and documented internal control structure is pertinent to our ability to maintain accurate books and records, prevent and detect fraud, maintain segregation of duties, report timely financial results and to properly comply with management’s requirements to report on the effectiveness of internal controls over financial reporting pursuant to the Sarbanes-Oxley Act. In determining key controls and appropriate internal controls for us management needs to further develop its risk assessment process, including a fraud risk assessment and monitoring program, that is appropriate for our size and complexity, to assess the risks of material misstatement in the significant accounts and disclosures and related assertions and to ensure implementation of controls to prevent or detect errors or fraud that could result in material misstatements.
Changes in internal control over financial reporting
During the three months ended June 30, 2013, there were no changes in our internal controls that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II. OTHER INFORMATION
Item 1. | Legal Proceedings |
We are not currently involved in any pending legal proceeding or litigation and we are not aware of any such proceedings contemplated by or against us or our property. To our knowledge, there are no material legal proceedings to which any our directors, officers or affiliates, or any beneficial owner of more than five percent of our common stock, or any associate of any of the foregoing, is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.
Item 1A. | Risk Factors |
In addition to the other information set forth in this report and the risk factor set forth below, you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2012. The risks discussed in our 2012 annual report could materially affect our business, financial condition and future results. The risks described in our 2012 annual report are not the only risks facing us. The recent sale of our TDG Assets and the loss of revenues from those products will materially affect our business unless new products and engineering service programs are developed to replace the previous business. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition or operating results. There are no material changes to the Risk Factors described in Item 1A in our 2012 annual report other than the impact of the recent sale of our TDG Assets as mentioned above.
25 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
Sale of Unregistered Securities - none
Purchase of Equity Securities - none
Item 3. | Defaults Upon Senior Securities |
We have determined that we are in default under a senior loan in the principal amount of $619,122 as of June 30, 2013. This loan default was cured by the repayment of the entire principal amount and related accrued interest upon closing of the Company’s August 5, 2013 public offering.
Item 4. | Mine Safety Disclosures |
Not Applicable
Item 5. | Other Information |
None
Item 6. | Exhibits |
Exhibit No. | Description | |
31.1 | Certification of the Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2 | Certification of the Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1 | Certification of the Chief Executive Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2 | Certification of the Chief Financial Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.CAL | XBRL Taxonomy Extension Calculation Link base Document | |
101.DEF | XBRL Taxonomy Extension Definition Link base | |
101.LAB | XBRL Taxonomy Extension Label Link base Document | |
101.PRE | XBRL Taxonomy Extension Presentation Link base Document |
26 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
VUZIX CORPORATION | ||||
Date: August 14, 2013 | By: |
/s/ Paul J. Travers | ||
Paul J. Travers | ||||
President, Chief Executive Officer | ||||
(Principal Executive Officer) | ||||
Date: August 14, 2013 | By: |
/s/ Grant Russell | ||
Grant Russell | ||||
Executive Vice President and Chief Financial Officer | ||||
(Principal Financial and Accounting Officer) |
27 |